Table 3.
Variable | UV Model HR | p value | MV Model HR | p value |
---|---|---|---|---|
Age | 0.959 (0.917 to 1) | 0.0629 | 0.952 (0.896 to 1.01) | 0.104 |
Male sex | 1.49 (0.657 to 3.37) | 0.341 | ||
Number of SBRT treatments | 1.04 (0.964 to 1.13) | 0.3 | ||
Mean treatment BED | 0.987 (0.976 to 0.998) | 0.017 | 0.99 (0.978 to 1) | 0.106 |
Mean KPS | 0.911 (0.868 to 0.957) | 0.00018 | 0.912 (0.864 to 0.963) | 0.00083 |
Mean pretreatment neutrophil count | 1.24 (1.06 to 1.45) | 0.006 | ||
Mean pretreatment lymphocyte count | 0.637 (0.312 to 1.3) | 0.216 | ||
Mean pretreatment NTLR | 1.11 (1.04 to 1.19) | 0.003 | 1.14 (1.05 to 1.24) | 0.0023 |
Received concurrent therapy | 1.87 (0.742 to 4.69) | 0.185 |
NLTR Neutrophil-to-lymphocyte ratio; SBRT stereotactic body radiotherapy; BED biologic equivalent dose; KPS Karnofsky performance status.